News & Events

HaemaLogiX announces collaboration with the Peter MacCallum Cancer Centre

5 February 2021

Image-empty-state.png

Orphan Drug Designation for KappaMab transferred to HaemaLogiX

29 January 2021

Image-empty-state.png

HaemaLogiX announces issuance of Australian patent for LMA

22 January 2021

Image-empty-state.png

HaemaLogiX Announces the Outcomes of Two Innovation Connections Grant Projects

16 October 2020

Image-empty-state.png

Bryce Carmine to present at AusBiotech & Invest 2020

9 October 2020

Image-empty-state.png

HaemaLogiX announces results of collaboration with CellVec

2 October 2020

Image-empty-state.png

HaemaLogiX announces issuance of Australian patent for KMA.CAR

25 September 2020

Image-empty-state.png

Prof Andrew Spencer presents KappaMab Phase 2b interim analysis results at ASH 2019

8 December 2019

Image-empty-state.png

HaemaLogiX initiates collaboration with Universidad de Navarra

5 November 2019

Image-empty-state.png

HaemaLogiX initiates collaboration with TPL Path Labs

7 May 2019

Image-empty-state.png

KMA.CAR-T cell preclinical data poster presentation at AACR 2018

16 April 2018

Image-empty-state.png